trazodone has been researched along with eugenosedin-a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, IJ; Liu, HW; Lo, YC; Shen, KP; Wu, BN; Yang, RC | 1 |
| Chen, IJ; Hsieh, SL; Liou, SF; Shen, KP; Wu, BN | 1 |
2 other study(ies) available for trazodone and eugenosedin-a
| Article | Year |
|---|---|
Antioxidant eugenosedin-A protects against lipopolysaccharide-induced hypotension, hyperglycaemia and cytokine immunoreactivity in rats and mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Antioxidants; Aorta, Thoracic; Blood Glucose; Cytokines; Free Radical Scavengers; Hyperglycemia; Hypotension; In Vitro Techniques; Lipid Peroxidation; Lipopolysaccharides; Mice; Mice, Inbred ICR; Oxidants; Oxidative Stress; Peroxides; Piperazines; Rats; Rats, Wistar; Survival Analysis; Trazodone | 2005 |
Eugenosedin-A amelioration of lipopolysaccharide-induced up-regulation of p38 MAPK, inducible nitric oxide synthase and cyclooxygenase-2.
Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Aorta, Thoracic; Ascorbic Acid; Blotting, Western; Cyclooxygenase 2; Endotoxemia; Guanidines; Hydrogen Peroxide; In Vitro Techniques; Lipopolysaccharides; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type II; Organ Specificity; p38 Mitogen-Activated Protein Kinases; Piperazines; Rats; Rats, Wistar; Serotonin Antagonists; Trazodone; Up-Regulation; Yohimbine | 2007 |